Skip to main content
Log in

If priced properly, new otitis media vaccine may be cost-effective

  • Clinical study
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. O'Brien MA, Prosser LA, Paradise JL, Ray GT, Kulldorff M, Kurs-Lasky M, Hinrichsen VL, Mehta J, Colborn DK, Lieu TA.New vaccines against otitis media: projected benefits and cost-effectiveness. Pediatrics 123: 1452-1463, No. 6, Jun 2009

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

If priced properly, new otitis media vaccine may be cost-effective. Pharmacoecon. Outcomes News 583, 6 (2009). https://doi.org/10.2165/00151234-200905830-00013

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200905830-00013

Keywords

Navigation